Drugs Regulator
- All
- News
- Videos
-
Health Ministry Bans Nimesulide Oral Doses Above 100 Mg Over Safety Concerns
The government has banned the manufacture, sale and distribution of all oral formulations of pain and fever medications, containing Nimesulide above 100 milligrams in immediate release dosage form, with immediate effect.
-
Ensure Weight Loss Drugs Are Safe, Legal Before Use In 2026: UK Health Agency
New Year is the time for many people to pledge reforms in habits and lifestyle, something resorting to drastic measures, but UK's Medicines and Healthcare products Regulatory Agency (MHRA) has urged the people to make sure an
-
Government Approves 108 Labs For Quality Testing Of Ayurvedic, Siddha And Unani Drugs
A total of 108 laboratories have been approved for quality testing of Ayurvedic, Siddha and Unani drugs, said Ayush Minister Prataprao Jadhav.
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
Weight Loss Drugs In India: The Rise Of GLP-1s In 2025
GLP-1 receptor agonists mimic the action of the glucagon-like peptide-1 hormone, which is involved in the regulation of appetite and insulin secretion. When administered, these medications stimulate insulin production.
-
Food Safety Officials Confiscate 595 Kilos Of Substandard Food In Lucknow
The crackdown was part of a 10-day statewide drive to make sure that the Food Safety and Standards Act's safety and hygiene regulations were followed properly.
-
New Study Highlights Drug Pricing And Regulation Issues In India
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
-
Central Drug Regulator Blames Tamil Nadu Lapses For Syrup Tragedy: Sources
The central drug regulator has blamed the negligence of Tamil Nadu authorities for the cough syrup tragedy.
-
Cough Syrup Linked To Child Deaths In India Not Shipped To US: Drug Regulator
The US Food and Drug Administration confirmed on Friday that toxic cough syrups linked to children's deaths in India had not been shipped to the United States.
-
Amid Cough Syrup Deaths, Auditor Flags Madhya Pradesh's Mega Purchase Of Banned Drugs
Even as Madhya Pradesh reels from the tragic deaths of 23 children in Chhindwara due to a toxic cough syrup, a new revelation from the Comptroller and Auditor General has exposed a deeper crisis in the state's drug regulation and procurement system.
-
364 Violations Found At Pharma Company Behind 'Killer' Cough Syrup: Sources
The pharmaceutical company, Sresan Pharma, at the centre of the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh was found to be supplying the cough syrup without testing it, said a top source.
-
Drug Regulator's Advisory Over Lapses Amid Outrage Over Cough Syrup Deaths
India's top drug regulator has issued an advisory over serious lapses in pharmaceutical manufacturing practices, amid growing outrage over child deaths allegedly linked to contaminated cough syrups.
-
US Drug Regulator's Ousted Vaccine Chief Vinay Prasad Is Returning To Agency
A Food and Drug Administration official is getting his job back as the agency's top vaccine regulator, less than two weeks after he was pressured to step down at the urging of biotech executives, patient groups and conservative allies of Trump.
-
Centre Flags Carcinogen Fears On Acidity Medicine Ranitidine, Orders Probe
The Central Drugs Standard Control Organisation (CDSCO) has directed all state and union territory drug regulators to ensure manufacturers of Ranitidine -- a commonly used acidity medicine --monitor NDMA levels.
-
EU Regulator Approves Twice-Yearly Injectable Drug For HIV Prevention
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.
-
Health Ministry Bans Nimesulide Oral Doses Above 100 Mg Over Safety Concerns
The government has banned the manufacture, sale and distribution of all oral formulations of pain and fever medications, containing Nimesulide above 100 milligrams in immediate release dosage form, with immediate effect.
-
Ensure Weight Loss Drugs Are Safe, Legal Before Use In 2026: UK Health Agency
New Year is the time for many people to pledge reforms in habits and lifestyle, something resorting to drastic measures, but UK's Medicines and Healthcare products Regulatory Agency (MHRA) has urged the people to make sure an
-
Government Approves 108 Labs For Quality Testing Of Ayurvedic, Siddha And Unani Drugs
A total of 108 laboratories have been approved for quality testing of Ayurvedic, Siddha and Unani drugs, said Ayush Minister Prataprao Jadhav.
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
Weight Loss Drugs In India: The Rise Of GLP-1s In 2025
GLP-1 receptor agonists mimic the action of the glucagon-like peptide-1 hormone, which is involved in the regulation of appetite and insulin secretion. When administered, these medications stimulate insulin production.
-
Food Safety Officials Confiscate 595 Kilos Of Substandard Food In Lucknow
The crackdown was part of a 10-day statewide drive to make sure that the Food Safety and Standards Act's safety and hygiene regulations were followed properly.
-
New Study Highlights Drug Pricing And Regulation Issues In India
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
-
Central Drug Regulator Blames Tamil Nadu Lapses For Syrup Tragedy: Sources
The central drug regulator has blamed the negligence of Tamil Nadu authorities for the cough syrup tragedy.
-
Cough Syrup Linked To Child Deaths In India Not Shipped To US: Drug Regulator
The US Food and Drug Administration confirmed on Friday that toxic cough syrups linked to children's deaths in India had not been shipped to the United States.
-
Amid Cough Syrup Deaths, Auditor Flags Madhya Pradesh's Mega Purchase Of Banned Drugs
Even as Madhya Pradesh reels from the tragic deaths of 23 children in Chhindwara due to a toxic cough syrup, a new revelation from the Comptroller and Auditor General has exposed a deeper crisis in the state's drug regulation and procurement system.
-
364 Violations Found At Pharma Company Behind 'Killer' Cough Syrup: Sources
The pharmaceutical company, Sresan Pharma, at the centre of the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh was found to be supplying the cough syrup without testing it, said a top source.
-
Drug Regulator's Advisory Over Lapses Amid Outrage Over Cough Syrup Deaths
India's top drug regulator has issued an advisory over serious lapses in pharmaceutical manufacturing practices, amid growing outrage over child deaths allegedly linked to contaminated cough syrups.
-
US Drug Regulator's Ousted Vaccine Chief Vinay Prasad Is Returning To Agency
A Food and Drug Administration official is getting his job back as the agency's top vaccine regulator, less than two weeks after he was pressured to step down at the urging of biotech executives, patient groups and conservative allies of Trump.
-
Centre Flags Carcinogen Fears On Acidity Medicine Ranitidine, Orders Probe
The Central Drugs Standard Control Organisation (CDSCO) has directed all state and union territory drug regulators to ensure manufacturers of Ranitidine -- a commonly used acidity medicine --monitor NDMA levels.
-
EU Regulator Approves Twice-Yearly Injectable Drug For HIV Prevention
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.
